Correction (DOI:10.1016/j.jcin.2008.03.019);Prevalence, Predictors, and Impact of Conservative Medical Management for Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Who Have Angiographically Documented Significant Coronary Disease

JACC: Cardiovascular Interventions

Volumn 1, Issue 4, 2008, Pages 369-378

  Chan, Mark Y ^a   Mahaffey, Kenneth W ^a   Sun, Lena J ^a   Pieper, Karen S ^a   White, Harvey D ^b   Aylward, Philip E ^c   Ferguson, James J ^d   Califf, Robert M ^a   Roe, Matthew T ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

conservative medical management; coronary artery disease; non ST segment elevation acute coronary syndrome; prognosis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADOLESCENT; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; FEMALE; HEART CATHETERIZATION; HEART REINFARCTION; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCHOOL CHILD;

EID: 49749120012     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.09.003     Document Type: Erratum

References (30)

1. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50 (2007) e1-e157
2. Bassand J.P., Hamm C.W., Ardissino D., et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 28 (2007) 1598-1660
3. Shavelle D.M., Parsons L., Sada M.J., French W.J., and Every N.R. Is there a benefit to early angiography in patients with ST-segment depression myocardial infarction?. An observational study. Am Heart J 143 (2002) 488-496
4. Fox K.A., Poole-Wilson P.A., Henderson R.A., et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 360 (2002) 743-751
5. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet 1999;354:708-15.
6. McCullough P.A., O'Neill W.W., Graham M., et al. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial. J Am Coll Cardiol 32 (1998) 596-605
7. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB trial. Thrombolysis in Myocardial Ischemia. Circulation 89 (1994) 1545-1556
8. Gogo Jr. P.B., Dauerman H.L., Mulgund J., et al. Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative). Am J Cardiol 99 (2007) 1222-1226
9. Ferguson J.J., Califf R.M., Antman E.M., et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 292 (2004) 45-54
10. Mahaffey K.W., Cohen M., Garg J., et al. High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial. JAMA 294 (2005) 2594-2600
11. Eagle K.A., Lim M.J., Dabbous O.H., et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 291 (2004) 2727-2733
12. Bhatt D.L., Roe M.T., Peterson E.D., et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA 292 (2004) 2096-2104
13. Monteiro P. Portuguese Registry on Acute Coronary Syndromes. Impact of early coronary artery bypass graft in an unselected acute coronary syndrome patient population. Circulation 114 1 Suppl (2006) I467-I472
14. Wang T.Y. Challenges of using peri-procedural myocardial infarction as a quality measure among patients undergoing percutaneous coronary intervention (abstr). Circulation 116 (2007) II-X
15. Anderson J.R., Cain K.C., and Gelber R.D. Analysis of survival by tumor response. J Clin Oncol 1 (1983) 710-719
16. Zhou Z., Rahme E., Abrahamowicz M., et al. Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods. Am J Epidemiol 162 (2005) 1016-1023
17. Bavry A.A., Kumbhani D.J., Rassi A.N., Bhatt D.L., and Askari A.T. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol 48 (2006) 1319-1325
18. Chew D.P., Huang Z., Pieper K.S., et al. Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy. Am Heart J 155 (2008) 239-244
19. Eagle K.A., Guyton R.A., Davidoff R., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 44 (2004) e213-e310
20. Morrison D.A., Sethi G., Sacks J., et al. Angina With Extremely Serious Operative Mortality Evaluation. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J Am Coll Cardiol 40 (2002) 1951-1954
21. FDA Statement on Coronary Drug-Eluting Stents (September 14, 2006). http://www.fda.gov/cdrh/news/091406.html Accessed February 19, 2008
22. Ko D.T., Mamdani M., and Alter D.A. Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA 291 (2004) 1864-1870
23. de Winter R.J., Windhausen F., Cornel J.H., et al. Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 353 (2005) 1095-1104
24. Alexander K.P., Chen A.Y., Roe M.T., et al. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA 294 (2005) 3108-3116
25. Fox K.A., Mehta S.R., Peters R., et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) trial. Circulation 110 (2004) 1202-1208
26. Wiviott S.D., Braunwald E., McCabe C.H., et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357 (2007) 2001-2015
27. Cannon C.P., Braunwald E., McCabe C.H., et al. Pravastatin or atorvastatin evaluation and infection therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504
28. Cannon C.P., Steinberg B.A., Murphy S.A., Mega J.L., and Braunwald E. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol 48 (2006) 438-445
29. Han J.H., Chandra A., Mulgund J., et al. Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. Am J Med 119 (2006) 248-254
30. SYNERGY Executive Committee. The SYNERGY trial: study design and rationale. Am Heart J 143 (2002) 952-960